Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC017 in Treatment-Naïve HIV-Infected Adults
NCT06719310Phase 2Completed
- Sponsor
- Aidea Pharma
- Start
- Aug 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of asuptegravir in human immunodeficiency virus infection (HIV), sponsored by Aidea Pharma. Started Aug 2024; status: completed.
02
Drugs
asuptegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT06719310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06719310.